MedPath
TGA Approval

NUBEQA darolutamide 300 mg tablet bottle (317242)

317242

NUBEQA darolutamide 300 mg tablet bottle

Bayer Australia Ltd

February 26, 2020

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-01415-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-PI-01276-1

Active Ingredients

darolutamide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NUBEQA darolutamide 300 mg tablet bottle (317242) - TGA 批准文号 | MedPath